Related Experiment Videos
Hematologic disorders and growth factor support in HIV infection
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Hematology/Oncology Clinics of North America
|October 1, 1996
Summary
Human immunodeficiency virus (HIV) disease causes various blood cell disorders and coagulation problems. This review covers HIV-related hematologic issues and the use of growth factors.
Area of Science:
- Hematology
- Immunology
- Infectious Diseases
Background:
- Human immunodeficiency virus (HIV) infection is associated with a wide range of hematologic abnormalities.
- These disorders affect blood cell production, survival, and function.
- Coagulation parameters can also be altered due to disruptions in immunoglobulin or factor production.
Purpose of the Study:
- To review the clinical manifestations of hematologic disorders in HIV disease.
- To discuss the underlying pathophysiology of these abnormalities.
- To explore the potential role of growth factor support in managing these conditions.
Main Methods:
- Literature review of existing studies on HIV-related hematologic disorders.
- Analysis of pathophysiology and clinical presentations.
- Discussion of therapeutic strategies, including growth factor support.
Main Results:
- HIV disease commonly leads to abnormalities in blood cell generation, survival, and function.
- Coagulation disturbances, including immunoglobulin and factor production issues, are frequently observed.
- Growth factors represent a potential therapeutic avenue for managing these hematologic complications.
Conclusions:
- Hematologic disorders are a significant and multifaceted aspect of HIV disease progression.
- Understanding the pathophysiology is crucial for effective management.
- Growth factor therapy warrants consideration for addressing specific hematologic abnormalities in HIV patients.